Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 14 studies | 23% ± 6% | |
| lung | 11 studies | 30% ± 11% | |
| kidney | 6 studies | 22% ± 5% | |
| intestine | 6 studies | 23% ± 12% | |
| brain | 6 studies | 23% ± 5% | |
| eye | 4 studies | 26% ± 13% | |
| bone marrow | 4 studies | 17% ± 1% | |
| uterus | 4 studies | 25% ± 11% | |
| liver | 3 studies | 30% ± 17% | |
| lymph node | 3 studies | 25% ± 11% | |
| breast | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2630.47 | 1445 / 1445 | 100% | 21.41 | 183 / 183 |
| ovary | 100% | 2598.28 | 180 / 180 | 100% | 29.21 | 430 / 430 |
| stomach | 100% | 2162.91 | 359 / 359 | 100% | 23.07 | 286 / 286 |
| brain | 100% | 2795.88 | 2641 / 2642 | 100% | 35.44 | 705 / 705 |
| breast | 100% | 2808.97 | 459 / 459 | 100% | 26.93 | 1114 / 1118 |
| lung | 100% | 2403.42 | 576 / 578 | 100% | 27.93 | 1154 / 1155 |
| skin | 100% | 2906.00 | 1809 / 1809 | 99% | 28.44 | 469 / 472 |
| intestine | 100% | 2444.84 | 966 / 966 | 99% | 25.97 | 523 / 527 |
| prostate | 100% | 2132.30 | 245 / 245 | 99% | 27.84 | 498 / 502 |
| thymus | 100% | 2381.96 | 653 / 653 | 99% | 28.94 | 600 / 605 |
| bladder | 100% | 2372.43 | 21 / 21 | 99% | 27.81 | 499 / 504 |
| kidney | 100% | 2146.00 | 89 / 89 | 99% | 24.52 | 891 / 901 |
| pancreas | 100% | 1452.45 | 328 / 328 | 99% | 24.66 | 176 / 178 |
| uterus | 100% | 2799.01 | 170 / 170 | 99% | 29.08 | 453 / 459 |
| adrenal gland | 100% | 2672.28 | 258 / 258 | 98% | 30.01 | 225 / 230 |
| liver | 100% | 1393.08 | 225 / 226 | 97% | 20.16 | 393 / 406 |
| adipose | 100% | 2779.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3009.23 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.51 | 29 / 29 |
| muscle | 100% | 3499.84 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1900.69 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 27.09 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 15.21 | 1 / 1 |
| eye | 0% | 0 | 0 / 0 | 99% | 22.96 | 79 / 80 |
| heart | 98% | 1999.67 | 841 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 94% | 1353.28 | 873 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006915 | Biological process | apoptotic process |
| GO_0071816 | Biological process | tail-anchored membrane protein insertion into ER membrane |
| GO_0045050 | Biological process | protein insertion into ER membrane by stop-transfer membrane-anchor sequence |
| GO_0072546 | Cellular component | EMC complex |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0032977 | Molecular function | membrane insertase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | EMC4 |
| Protein name | ER membrane protein complex subunit 4 (Cell proliferation-inducing gene 17 protein) (Transmembrane protein 85) ER membrane protein complex subunit 4 ER membrane protein complex subunit 4 (Transmembrane protein 85) |
| Synonyms | PIG17 HSPC184 TMEM85 |
| Description | FUNCTION: Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins . Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues . Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices . It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes . By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors . By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes (Probable). . |
| Accessions | ENST00000559078.5 H0YMH5 Q5J8M3 H0YKL2 ENST00000559421.1 ENST00000560911.5 ENST00000558102.1 H0YNK0 ENST00000249209.8 [Q5J8M3-2] ENST00000267750.9 [Q5J8M3-1] ENST00000558205.5 H0YNK8 S4R329 H0YLP8 ENST00000561372.1 H0YN63 H0YK61 ENST00000557879.1 ENST00000560947.1 |